Home › NDC Lookup › RxCUI directory › RxCUI 2745138

5 ML fulvestrant 50 MG/ML Prefilled Syringe [Cligavyx] — RxCUI 2745138

RxNorm drug concept · Semantic branded drug
RxCUI 2745138 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2745138
Official name5 ML fulvestrant 50 MG/ML Prefilled Syringe [Cligavyx]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as5 ML Cligavyx 50 MG/ML Prefilled Syringe; CLIGAVYX 250 MG in 5 ML Prefilled Syringe; Cligavyx 250 MG per 5 ML Prefilled Syringe
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Fulvestrant Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats HR-positive advanced breast cancer in postmenopausal women. It can be used alone or with ribociclib, palbociclib or abemaciclib, depending on your situation. Your oncolog...
  • A healthcare professional gives it as two slow injections, one in each buttock. You get doses on Days 1, 15 and 29, then once a month. Keep your appointments, and call your care te...
  • Common ones include injection site pain, nausea, bone or joint pain, headache, tiredness and hot flashes. Your liver enzymes may also rise, so your team may check blood tests. Thes...
  • Call for hives or swelling of the face, lips or throat, which could be an allergic reaction. Also call for shooting pain or numbness in the buttock or leg, or unusual bleeding or b...
📖 Read our full Fulvestrant Injection guide →

🕸️ Concept Web — How 5 ML fulvestrant 50 MG/ML Prefilled Syringe [Cli... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 5 ML fulvestrant 50 MG/ML Prefilled Syringe [Cligavyx] RxCUI 2745138

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Fulvestrant 282357
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cligavyx 2745134
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fulvestrant Prefilled Syringe 727760
    • Fulvestrant Injectable Product 1156671
    • Fulvestrant Prefilled Syringe [Cligavyx] 2745137
    • Cligavyx Injectable Product 2745136
    • Prefilled Syringe 721656
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Fulvestrant 50 MG/ML [Cligavyx] SBDC · 2745135
  • Fulvestrant Prefilled Syringe [Cligavyx] SBDF · 2745137
  • Cligavyx Injectable Product SBDG · 2745136
  • Cligavyx BN · 2745134

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2745138 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
83831-0159-02 2 SYRINGE, GLASS in 1 CARTON (83831-159-02) / 5 mL in 1 SYR... CLIGAVYX Avyxa Pharma, LLC 2026-07-01
Observed labelers: Avyxa Pharma, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.